I
Intensity Therapeutics, Inc. (INTS)
NCM – Real vaqt narxi. Valyuta: USD
4.10
+0.01 (0.20%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.15
+0.05 (1.22%)
Bozordan keyin: Jun 26, 2026, 6:33 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
4.10
+0.01 (0.20%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.15
+0.05 (1.22%)
Bozordan keyin: Jun 26, 2026, 6:33 PM EDT
Intensity Therapeutics, Inc., kechki bosqichdagi klinik biotexnologiya kompaniyasi, Qo'shma Shtatlarda saratonning mintaqaviy va tizimli takrorlanishi va metastazini davolashni ta'minlash bilan shug'ullanadi. Uning asosiy mahsulot nomzodi INT230-6 ni o'z ichiga oladi, bu yumshoq to'qima sarkomasi uchun 3-bosqichli klinik tadqiqotlarda; va 2-bosqichli klinik sinovlarda bo'lgan neoad'yuvant va metastatik uchlik-negativ ko'krak bezi saratoni. Kompaniya 2012 yilda ro'yxatga olingan va Shelton, Konnektikutda joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. James M. Ahlers | Executive Vice President of Corporate Finance |
| Mr. John Wesolowski CPA, M.B.A. | Principal Accounting Officer & Controller |
| Mr. Joseph Talamo CPA, M.B.A. | Chief Financial Officer |
| Mr. Lewis H. Bender M.A., M.B.A., M.S. | Founder, President, CEO & Chairman of the Board |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-16 | 8-K | intensity-20260616.htm |
| 2026-05-07 | 8-K | intensity-20260507.htm |
| 2026-05-07 | 10-Q | intensity-20260331.htm |
| 2026-04-30 | DEF 14A | intensity-20260430.htm |
| 2026-03-27 | 8-K | intensity-20260327.htm |
| 2026-03-27 | 10-K | intensity-20251231.htm |
| 2026-03-23 | 8-K | intensity-20260323.htm |
| 2026-03-06 | 8-K | intensity-20260305.htm |
| 2026-03-05 | 8-K | intensity-20260305.htm |
| 2026-02-13 | 8-K | intensity-20260213.htm |